Related Experiment Videos

Complete pathologic response of metastatic cutaneous squamous cell carcinoma and allograft rejection after treatment

David M Miller^1,2, Beverly E Faulkner-Jones³, James R Stone⁴

¹Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts.

JAAD Case Reports

|September 22, 2017

Abstract

No abstract available in PubMed .

Keywords:

DICB, dual immune checkpoint blockade ICB, immune checkpoint blockade cSCC, cutaneous squamous cell carcinoma immune checkpoint blockade ipi/nivo, ipilimumab and nivolumab ipilimumab mcSCC, metastatic cSCC nivolumab squamous cell carcinoma

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Intrinsic and non-cell-autonomous roles for the neurodevelopmental syndrome-linked transcription factor UNC-3/EBF.

Nature communications·2026

Venous thromboembolism and bleeding in advanced melanoma: a propensity-matched cohort analysis comparing first-line immunotherapy and targeted therapy.

Research and practice in thrombosis and haemostasis·2026

Standardization of Retinal Vasculitis Terminology With Consensus Definitions From a Delphi Panel.

JAMA ophthalmology·2026

Immune Checkpoint Inhibitors for Advanced Periocular/Orbital Squamous Cell Carcinoma of Cutaneous Origin: Durable Responses in a Retrospective Cohort.

Ophthalmic plastic and reconstructive surgery·2026

Frontline immunotherapy with response-guided subsequent treatment (FIRST) in cutaneous squamous cell carcinoma: a Bayesian causal analysis of dose intensity, early benefit, and treatment de-escalation.

Journal for immunotherapy of cancer·2026

Liquid biopsy in cutaneous oncology: Current practice and future directions.

Journal of the American Academy of Dermatology·2026

See all related articles